From blur to breaktHrough
We’re decoding the immune system with unprecedented resolution and scale to transform how we understand, diagnose and treat disease.
Highlights
Our science
We measure over 100 million immune data points from a single blood sample, building the world’s largest immune dataset and powering a new era of HD Immunology.
For decades, the immune system has been mapped with tools that are too blunt to capture its true complexity. Our multi-omic platform resolves 2,500 discrete immune cell subsets in real time to generate the world’s largest and most detailed immune picture ever assembled at clinical scale.
Our Programmes
We are transforming our understanding of the immune system with HD Immunology. This will power the next generation of precision medicine, starting with the following programmes:
HSCT
We are progressing a first-in-class predictive screening tool for graft efficacy in Hematopoietic Stem Cell Transplantation
SOT
We are developing tools that predict graft rejection in Solid Organ Transplantation
I-O
We are identifying predictive signatures of response and adverse events to checkpoint inhibition in Immuno-Oncology
PARTNERING WITH IMU
We are working with partners across the spectrum of immune health and disease.
IMU works with clinical research groups, pharma, biotech and diagnostics companies to turn immune insight into clinical action. Working with our partners is crucial to decode disease mechanisms, improve drug discovery and development and deliver immune driven precision medicine.
About Us
Our company is built on decades of pioneering research at the Francis Crick Institute and King's College London
We are a team of immunologists, computational biologists, data scientists, engineers and company builders working at the intersection of cutting-edge science and real-world clinical impact. We are driven by our mission to revolutionize our understanding of the immune system and transform how we diagnose and treat disease.
OUr INVESTORS
